Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BMC Research Notes is Scopus-indexed (Q2, CiteScore 2.6), WoS ESCI, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1756-0500Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 227 / 669 | 66th | Q2 |
| Biochemistry, Genetics and Molecular Biology (all) | 132 / 223 | 41st | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 2.6.
BMC Research Notes is Q2 in Medicine (all) (rank 227 of 669) and Q3 in Biochemistry, Genetics and Molecular Biology (all) (rank 132 of 223), by CiteScore 2025.
BMC Research Notes is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.6, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.441, quartile Q3, with an H-index of 107.
The publisher lists an article processing charge of about US$1,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BMC Research Notes is published by BioMed Central Ltd. Its ISSN is 1756-0500.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
BMC Research Notes has an h-index of 140 and a 2-year mean of 1.91 citations per paper (OpenAlex). Its Scopus CiteScore is 2.6, quartile Q2. On 2-year citations it ranks #147 of 646 Scopus journals in Medicine (all).
BMC Research Notes published 555 papers in 2025; its busiest recent year was 2018 with 928. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from Iran (16.2%), United States (10.3%) and China (8.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 14 retracted papers are recorded (1.3 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.